Search results
Showing 466 to 480 of 494 results for anxiety
Cardiovascular disease: risk assessment and reduction, including lipid modification (NG238)
This guideline covers identifying and assessing risk of cardiovascular disease (CVD) in adults without established CVD. It covers lifestyle changes and lipid-lowering treatment (including statins) for primary and secondary prevention of CVD, and includes guidance for people who also have diabetes or chronic kidney disease.
Interventional procedures programme manual
Guide to the methods of technology appraisal 2013
This guide describes the methods and processes, including expected timescales, that NICE follows when carrying out health technology evaluations. The methods and processes are designed to produce robust guidance for the NHS in an open, transparent and timely way, with appropriate contribution from stakeholders. Organisations invited to contribute to health technology evaluation development should read this manual in conjunction with the NICE health technology evaluation topic selection: the manual. All documents are available on the NICE website.
Developing NICE guidelines: the manual
New NICE draft guidance on identifying, assessing and managing harmful gambling published
NICE’s priority is to get the best care to patients fast while ensuring value for the taxpayer.
Nine treatment options to be made available for adults with depression or an anxiety disorder
Six digitally enabled therapies for adults with anxiety disorders and three for adults with depression have been recommended for use in the NHS while further data is gathered, NICE has said.
NICE's Early Value Assessment for Medtech: panning for nuggets of innovation gold
Jeanette Kusal, Mark Salmon and Sarah Byron discuss NICE's Early Value Assessment for Medtech and how it will offer a rapid assessment of digital products, devices and diagnostics for clinical effectiveness and value for money.
Dr Sam Roberts, chief executive at NICE, looks back at NICE's achievements over the past year and discusses our priorities for 2023.
NICE's support for rebuilding capacity in non-COVID health services
Director of our Centre for Guidelines, Paul Chrisp, discusses how NICE can help the NHS and wider care sector restore services most affected by the COVID-19 pandemic
Recent research has found that that the number of children being treated with epilepsy has fallen dramatically in the last decade.
It is the first recommendation to be issued by NICE’s diagnostics advisory committee via its Early Value Assessment pilot project.
New online and mobile app for depression should be trialled on the NHS, says NICE
NICE says that online and mobile programme Deprexis could help adults with depression get faster access to care and it should be tested out in NHS services.
NICE backed award for physiotherapist helping to improve patients' quality of life
Laura McNeillie picks up NICE award at Chief Allied Health Professions Officer’s awards